{"id":"https://openalex.org/W755577047","doi":"https://doi.org/10.25401/cardiffmet.20337396","title":"The effects of peroxisome proliferator-activated receptor-gamma (PPARy) agonists on monocytic cell activation and endothelial function in diabetes","display_name":"The effects of peroxisome proliferator-activated receptor-gamma (PPARy) agonists on monocytic cell activation and endothelial function in diabetes","publication_year":2005,"publication_date":"2005-01-03","ids":{"openalex":"https://openalex.org/W755577047","doi":"https://doi.org/10.25401/cardiffmet.20337396","mag":"755577047"},"language":"en","primary_location":{"id":"pmh:oai:repository.cardiffmet.ac.uk:10369/6446","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10369/6446","pdf_url":"http://hdl.handle.net/10369/6446","source":{"id":"https://openalex.org/S4306401326","display_name":"Cardiff Metropolitan Research Repository (Cardiff Metropolitan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8408910","host_organization_name":"Cardiff Metropolitan University","host_organization_lineage":["https://openalex.org/I8408910"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10369/6446","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086241664","display_name":"Maninder Kaur Ahluwalia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ahluwalia, Maninder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5086241664"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.871999979019165},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9879999756813049},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9909999966621399},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9169999957084656},{"id":"https://openalex.org/keywords/advanced-glycation-end-products","display_name":"advanced glycation end products","score":0.9190000295639038},{"id":"https://openalex.org/keywords/receptor-for-advanced-glycation-end-products","display_name":"receptor for advanced glycation end products","score":0.8740000128746033},{"id":"https://openalex.org/keywords/monocyte-activation","display_name":"monocyte activation","score":0.6370000243186951},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.9779999852180481},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8360000252723694},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.9089999794960022},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.8230000138282776},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.8410000205039978},{"id":"https://openalex.org/keywords/vascular-inflammation","display_name":"vascular inflammation","score":0.36899998784065247}],"concepts":[{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.74470454454422},{"id":"https://openalex.org/C127078168","wikidata":"https://www.wikidata.org/wiki/Q138639","display_name":"Peroxisome","level":3,"score":0.5143693685531616},{"id":"https://openalex.org/C7341990","wikidata":"https://www.wikidata.org/wiki/Q10331450","display_name":"PPAR agonist","level":4,"score":0.500251293182373},{"id":"https://openalex.org/C130241916","wikidata":"https://www.wikidata.org/wiki/Q20970208","display_name":"Peroxisome proliferator-activated receptor gamma","level":4,"score":0.4960685670375824},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47917452454566956},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.46504417061805725},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45736369490623474},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43544548749923706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4353582561016083},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3810085952281952},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30825674533843994},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2733708620071411}],"mesh":[],"locations_count":5,"locations":[{"id":"pmh:oai:repository.cardiffmet.ac.uk:10369/6446","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10369/6446","pdf_url":"http://hdl.handle.net/10369/6446","source":{"id":"https://openalex.org/S4306401326","display_name":"Cardiff Metropolitan Research Repository (Cardiff Metropolitan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8408910","host_organization_name":"Cardiff Metropolitan University","host_organization_lineage":["https://openalex.org/I8408910"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},{"id":"pmh:oai:figshare.com:article/20337396","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/thesis/The_effects_of_peroxisome_proliferator-activated_receptor-gamma_PPARy_agonists_on_monocytic_cell_activation_and_endothelial_function_in_diabetes/20337396","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},{"id":"doi:10.25401/cardiffmet.20337396","doi":"https://doi.org/10.25401/cardiffmet.20337396","is_oa":true,"landing_page_url":"https://doi.org/10.25401/cardiffmet.20337396","pdf_url":null,"source":{"id":"https://openalex.org/S4306401326","display_name":"Cardiff Metropolitan Research Repository (Cardiff Metropolitan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8408910","host_organization_name":"Cardiff Metropolitan University","host_organization_lineage":["https://openalex.org/I8408910"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dissertation"},{"id":"doi:10.25401/cardiffmet.20337396.v1","doi":"https://doi.org/10.25401/cardiffmet.20337396.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25401/cardiffmet.20337396.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401326","display_name":"Cardiff Metropolitan Research Repository (Cardiff Metropolitan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8408910","host_organization_name":"Cardiff Metropolitan University","host_organization_lineage":["https://openalex.org/I8408910"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dissertation"},{"id":"mag:755577047","doi":null,"is_oa":false,"landing_page_url":"https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.629879","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:repository.cardiffmet.ac.uk:10369/6446","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10369/6446","pdf_url":"http://hdl.handle.net/10369/6446","source":{"id":"https://openalex.org/S4306401326","display_name":"Cardiff Metropolitan Research Repository (Cardiff Metropolitan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8408910","host_organization_name":"Cardiff Metropolitan University","host_organization_lineage":["https://openalex.org/I8408910"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W755577047.pdf","grobid_xml":"https://content.openalex.org/works/W755577047.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6926634923","https://openalex.org/W2144717552","https://openalex.org/W2030921297","https://openalex.org/W1968953786","https://openalex.org/W1976083910","https://openalex.org/W2100079215","https://openalex.org/W2031766286","https://openalex.org/W4254128803","https://openalex.org/W2098108405","https://openalex.org/W7081541291"],"abstract_inverted_index":{"Peroxisome":[0],"Proliferator-activated":[1],"Receptor-y":[2],"(PPARy)":[3],"is":[4,316],"a":[5,23],"ligand-activated":[6],"transcription":[7],"factor":[8],"responsible":[9],"for":[10,285],"controlling":[11,180],"genes":[12],"involved":[13,434],"in":[14,33,61,239,293,319,393,412],"lipid":[15],"and":[16,65,72,109,116,125,166,173,275,321,355,390,409,442,448,463],"glucose":[17],"metabolism.":[18],"The":[19,151],"thiazolidinediones":[20],"(TZDs)":[21],"are":[22,455],"class":[24],"of":[25,36,59,89,100,148,184,189,195,229,250,262,267,304,333,339,368,428,452],"synthetic":[26],"PPARy":[27,138,154,190,263,278,421],"ligands":[28],"used":[29],"as":[30,94,98,141],"anti-hyperglycaemic":[31],"agents":[32],"the":[34,57,83,146,149,177,181,187,193,288,294,296,302,307,311,331,336,340,379,387,425,432,445,461],"treatment":[35],"type":[37],"2":[38],"diabetes.":[39,90],"Recently":[40],"it":[41],"hasbeen":[42],"shown":[43],"that":[44,130,203,301,349,401,420],"these":[45,402,417,466],"agonists":[46,155,191,334,422],"have":[47],"additional":[48],"anti-inflammatory":[49,152,447],"properties":[50],"beyondtheir":[51],"metabolic":[52],"functions.":[53],"This":[54,366],"study":[55,328],"evaluated":[56],"role":[58,332],"TZDs":[60],"monocytic":[62,69,429],"cell":[63,70],"activation":[64,194],"endothelial":[66,396],"function.":[67],"Human":[68],"lines":[71],"peripheralmonocytes":[73],"were":[74,118],"stimulated":[75],"with":[76,254],"various":[77],"advanced":[78],"glycation":[79],"end-products":[80],"(AGEs)":[81],"tomimic":[82],"chronic":[84],"inflammatory":[85,426],"hlperglycaemic":[86],"state":[87],"typical":[88],"Release":[91],"ofcytokines,":[92],"such":[93],"TNF-o,":[95],"was":[96,103,128,133,198,201,245,271,291,347,363,399],"determined":[97,348],"indicators":[99],"inflammation.":[101],"Endothelialfunction":[102],"studied":[104,272],"using":[105],"rabbit":[106,343],"aortic":[107,112,344],"rings":[108],"primary":[110,395],"human":[111,394],"cellsPPARy":[113],"agonists,":[114],"GW7845":[115,350],"rosiglitazone,":[117],"obseryed":[119],"to":[120,157,217,378,436,457],"significantly":[121],"reduceAGE-induced":[122],"TNF-cr":[123,185,241],"expression":[124,270,284,290,392],"release.":[126],"It":[127,200,244,346,398],"demonstrated":[129],"this":[131,235,327],"reduction":[132],"not":[134,144,215,237,281,385],"completely":[135],"dependent":[136],"on":[137,192,265,335],"transcriptional":[139,274],"activity,":[140,207],"PPARyantagonists":[142],"did":[143,236,280,384],"negate":[145],"actions":[147],"agonist.":[150],"propertiesof":[153],"appeared":[156],"be":[158,437,458],"(i).":[159],"time-dependent,":[160],"(ii)":[161],"dose-dependent":[162],"(iii)":[163],"celltype":[164],"specific":[165],"(iv)":[167],"involve":[168,406],"two":[169,467],"distinct":[170],"pathways:":[171],"PPARy-dependent":[172],"PPART-independent.":[174],"To":[175],"elucidate":[176],"molecular":[178],"mechanisms":[179,433],"observed":[182],"inhibition":[183],"release":[186,389],"effect":[188,261],"ERKand":[196],"NF-rB":[197,221,230,251],"investigated.":[199],"found":[202],"rosiglitazone":[204,225],"reduced":[205],"gBSA-inducedERK":[206],"although":[208],"basal":[209,227],"levels":[210,228],"remained":[211],"unaffected.":[212],"Surprisingly,":[213],"rosiglitazonedid":[214],"appear":[216,435],"modulate":[218],"glycated":[219],"BSA-stimulated":[220],"DNA":[222,231],"binding":[223,232],"activity.Conversely,":[224],"increase":[226,282],"activity":[233],"but":[234],"result":[238],"NF-rB-dependent":[240],"gene":[242],"expression.":[243],"postulated":[246,400],"thatthis":[247],"up":[248],"regulation":[249,303],"might":[252],"interfere":[253],"signalling":[255,408],"processes":[256,427],"necessary":[257],"forinfl":[258],"ammatory":[259],"responses.The":[260],"agonist":[264,279,297,308],"receptor":[266],"AGE":[268],"(RAGE)":[269],"atboth":[273],"translational":[276],"level.":[277],"mRNA":[283],"RAGE,":[286],"however":[287],"protein":[289],"increased":[292,375],"presenceof":[295],"after":[298],"241'rs,":[299],"indicating":[300],"RAGE":[305],"by":[306,439,460],"maybe":[309],"at":[310],"post-transcriptional":[312],"and./or":[313],"post-translational":[314],"levels.PPARy":[315],"also":[317,329],"expressed":[318],"endothelium":[320],"vascular":[322,337],"smooth":[323,413],"muscle":[324,414],"cells.":[325,397,430],"Therefore":[326],"investigated":[330],"tone":[338],"vessel":[341],"wallin":[342],"rings.":[345],"(>20\u00a1tM)":[351],"inhibited":[352],"bothphenylephrine-induced":[353],"contraction":[354],"acetylcholine-induced":[356],"relaxation,":[357],"whereas":[358],"sodium":[359],"nitroprusside":[360],"(SNP)-induced":[361],"relaxation":[362,371],"slightly":[364],"improved.":[365],"enhancement":[367],"SNP":[369],"induced":[370],"may":[372],"indicate":[373,419],"an":[374],"sensitivity":[376],"ofVSMCs":[377],"exogenous":[380],"nitric":[381],"oxide.":[382],"GV/7845":[383],"influence":[386],"NO":[388],"eNOS":[391],"direct":[403],"vasomodulatory":[404],"effects":[405],"cGMP":[407],"calcium":[410],"trafficking":[411],"cells.Taken":[415],"together":[416],"findings":[418],"can":[423],"reduce":[424],"However":[431],"influenced":[438],"both":[440],"PPRE-dependent":[441],"PPRE-independent":[443],"pathwaysand":[444],"net":[446],"anti-atherogenic":[449],"clinical":[450],"benefits":[451],"TZD":[453],"therapy":[454],"likely":[456],"governed":[459],"interactions":[462],"balance":[464],"between":[465],"pathways.":[468]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}